|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008943,
umls-concept:C0025344,
umls-concept:C0028356,
umls-concept:C0040808,
umls-concept:C0043210,
umls-concept:C0059623,
umls-concept:C0232970,
umls-concept:C0332256,
umls-concept:C0628822,
umls-concept:C1457887,
umls-concept:C1561960,
umls-concept:C1705294,
umls-concept:C1707455,
umls-concept:C1948053,
umls-concept:C2347804,
umls-concept:C2587213,
umls-concept:C2603343
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2005-11-15
|
|
pubmed:abstractText |
To compare the efficacy of two sequential 17beta-estradiol (17beta-E2)/trimegestone (TMG) combinations with the sequential estradiol valerate (E2V)/norethisterone (NET) regimen in relieving climacteric symptoms.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0951-3590
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
74-81
|
|
pubmed:dateRevised |
2008-9-4
|
|
pubmed:meshHeading |
pubmed-meshheading:16294458-Administration, Oral,
pubmed-meshheading:16294458-Adult,
pubmed-meshheading:16294458-Double-Blind Method,
pubmed-meshheading:16294458-Drug Administration Schedule,
pubmed-meshheading:16294458-Drug Combinations,
pubmed-meshheading:16294458-Estradiol,
pubmed-meshheading:16294458-Estrogen Replacement Therapy,
pubmed-meshheading:16294458-Female,
pubmed-meshheading:16294458-Hot Flashes,
pubmed-meshheading:16294458-Humans,
pubmed-meshheading:16294458-Middle Aged,
pubmed-meshheading:16294458-Norethindrone,
pubmed-meshheading:16294458-Postmenopause,
pubmed-meshheading:16294458-Promegestone,
pubmed-meshheading:16294458-Prospective Studies,
pubmed-meshheading:16294458-Quality of Life,
pubmed-meshheading:16294458-Sleep Disorders,
pubmed-meshheading:16294458-Sweating,
pubmed-meshheading:16294458-Uterine Hemorrhage
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
A study of the control of climacteric symptoms in postmenopausal women following sequential regimens of 1 mg 17beta-estradiol and trimegestone compared with a regimen containing 1 mg estradiol valerate and norethisterone over a two-year period.
|
|
pubmed:affiliation |
Department of Gynaecology, Brussels Menopause Center, Avenue Winston Churchill 239, B-1180 Brussels, Belgium. bruno.pornel@menopausecenter.be
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Multicenter Study
|
